CP-347589

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCP-347589

Drug Alias NameCP-347589

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein-tyrosine kinases inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonists

TargetsProtein-tyrosine kinasesReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A